12 fiscal years, as filed with the SEC; every row links its evidence fact.
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $2.0M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-009411 |
| FY 2024 | $11.2M | 2024-01-01 – 2024-12-31 | evidence 0001493152-25-010146 |
| FY 2023 | $-2.9M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-009127 |
| FY 2022 | $500.0k | 2022-01-01 – 2022-12-31 | evidence 0001493152-24-009127 |
| FY 2021 | $16.1M | 2021-01-01 – 2021-12-31 | evidence 0001493152-23-007178 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-034761 |
| FY 2019 | $165.0k | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-032764 |
| FY 2018 | $428.0k | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-012434 |
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001144204-19-012434 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001144204-19-012434 |
| FY 2013 | $0 | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-019291 |
| FY 2012 | $7.7M | 2012-01-01 – 2012-12-31 | evidence 0001144204-14-019291 |
LIPOCINE INC. — all facts · Net Income · Operating Income · Cite as: FACTANKER, https://factanker.com/entity/052e281f-32c8-41aa-a3af-e96a6eed077e/serie/revenue